Bayer submits regulatory applications for oncology treatment combination of copanlisib and rituximab in the U.S. and EU

Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson’s disease

Bayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer

Researchers with unique ideas on helping farmers protect their crops selected as Bayer 2021 Grants4Ag awardees

Leaps by Bayer leads USD 90 Million Series B financing in digital health company Ada Health

Address by Werner Baumann

Chairman of the Board of Management

Bayer announces five-point plan to effectively address potential future Roundup™ claims

Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative Medicine

AskBio Announces IND for LION-101, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), Cleared to Proceed by U.S. FDA

Precision oncology treatment Larotrectinib submitted for marketing authorization in China